Skip to content

Clinical trials

Recruiting Phase 1 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Status: Recruiting Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20193
20202
20218
20226
202313
202420
202520
202626

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting99

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center6
Eli Lilly and Company3
AbbVie2
AstraZeneca2
Chongqing Precision Biotech Co., Ltd2
City of Hope Medical Center2
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd2
Jiangsu Hansoh Pharmaceutical Co., Ltd.2
National Cancer Institute (NCI)2
SystImmune Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms99
Breast Neoplasms31
Endometrial Neoplasms26
Carcinoma, Non-Small-Cell Lung20
Colorectal Neoplasms18
Uterine Cervical Neoplasms18
Stomach Neoplasms17
Pancreatic Neoplasms16
Squamous Cell Carcinoma of Head and Neck16
Neoplasm Metastasis14

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.